ANDREW J. RAE is Chief Financial Officer of Ability Biomedical
Corporation. He has a decade of experience in the biotechnology
field, most recently raising $15 million in venture funding as
Vice President, Finance and Corporate Affairs, Active Pass
Pharmaceuticals Inc. Mr. Rae has also served as a Biotechnology
Equities Analyst for Goepel Shields and Partners (now Raymond
James, Canada) and Consultant to Ventures West Management, a
prominent Canadian biotechnology venture capitalist.
Hans Keirstead - Ability Biomedical Corporation
February 24, 2003
